Emmanuelle di Tomaso

Author

Also Known As

E Di Tomaso, E di Tomaso, E. D. Tomaso, E. Di Tomaso, E. di Tomaso, Emmanuelle D. Tomaso, Emmanuelle Di Tomaso, Emmanuelle Tomaso, Emmanuelle di Tomaso

185

Publications

20K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Novartis (Switzerland)Dana-Farber Cancer Institute Duke Medical Center

About

Emmanuelle di Tomaso is an author at Massachusetts General Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	10.6K
2	Health Sciences	7	7	2.6K
3	Natural Sciences	1	1	458
4	Social Sciences	1	1	389
5	Biochemistry	1	1	389

Emmanuelle di Tomaso

Publications

17.2K

Citations

H-Index

Page 1

	Year	Citations
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso, Nature Medicine AngiogenesisMedicineHuman Rectal CancerImmunologyPathology	2004	1.9K
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso, Cancer Cell Normalizes Tumor VasculatureNeuro-oncologyNovel TherapyMedicinePharmacology	2007	1.8K
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation Frank Winkler, Sergey V. Kozin, Ricky T. Tong, Cancer Cell Neuro-oncologyVascular NormalizationNuclear MedicineRadiation TherapyGlioma	2004	1.2K
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics Timothy P. Padera, Ananth Kadambi, Emmanuelle di Tomaso, Science Tumor BiologyAngiogenesisMedicineImmunologyPathology	2002	961
Cancer cells compress intratumour vessels Timothy P. Padera, Brian R. Stoll, Jessica B. Tooredman, Nature Tumor BiologyBiological MicroenvironmentsCancer CellsMatrix BiologyMedicine	2004	843
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Chang Geol Lee, M. Heijn, Emmanuelle di Tomaso, PubMed ImmunologyTumor BiologyRadiation MedicineAngiogenesisOncology	2000	681
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood Yong S. Chang, Emmanuelle di Tomaso, Donald M. McDonald, Proceedings of the National Academy of Sciences	2000	665
Herceptin acts as an anti-angiogenic cocktail Yotaro Izumi, Lei Xu, Emmanuelle di Tomaso, Nature Translational MedicineMedicineVascular PharmacologyVascular BiologyPharmacotherapy	2002	631
Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors Alain Pluen, Yves Boucher, Saroja Ramanujan, Proceedings of the National Academy of Sciences	2001	589
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial José Baselga, Seock‐Ah Im, Hiroji Iwata, The Lancet Oncology Advanced Breast CancerBreast OncologyOncologyClinical TrialsGynecology	2017	532

Page 1